Rap video is latest evidence in Insys trialA rap video used to motivate Insys Therapeutics’ salesforce into promoting higher doses of its opioid drug Subsys Share XRap video is latest evidence in Insys trialhttps://pharmaphorum.com/news/rap-video-is-latest-evidence-in-insys-trial/
Chinese patients to get new drugs before UK after Brexit – says CEOUS, European, Japanese and Chinese patients could get novel medicines ahead of patients in the UK after Brexit, Share XChinese patients to get new drugs before UK after Brexit – says CEOhttps://pharmaphorum.com/news/chinese-patients-new-drugs-before-uk-brexit-ceo/
Mylan launches Advair generic at 70% discount in USMylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the Share XMylan launches Advair generic at 70% discount in UShttps://pharmaphorum.com/news/mylan-launches-advair-generic-at-70-discount-in-us/
FDA panel backs J&J’s potential depression blockbusterA panel of advisers to the FDA has voted in favour of approving Johnson & Johnson’s experimental nasal Share XFDA panel backs J&J’s potential depression blockbusterhttps://pharmaphorum.com/news/fda-panel-backs-jjs-potential-depression-blockbuster/
Sanofi appoints its first chief digital officerSanofi has become the latest big pharma firm to appoint a chief digital officer, choosing Ameet Nathwani to Share XSanofi appoints its first chief digital officerhttps://pharmaphorum.com/news/sanofi-appoints-its-first-chief-digital-officer/
Novartis and Lilly CEOs back Trump plans to cut drug pricesCEOs from Novartis and Eli Lilly have backed US government proposals to cut out “middlemen” in the health Share XNovartis and Lilly CEOs back Trump plans to cut drug priceshttps://pharmaphorum.com/news/novartis-and-lilly-ceos-back-trump-plans-to-cut-drug-prices/
Call for better regulation of AI-based medical productsProducts based on artificial intelligence should be regulated like drugs, and those that are deemed unsafe should be Share XCall for better regulation of AI-based medical productshttps://pharmaphorum.com/news/call-for-better-regulation-of-artificial-intelligence/
GSK bolts-on immuno-oncology candidate with €3.7bn Merck dealGlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an Share XGSK bolts-on immuno-oncology candidate with €3.7bn Merck dealhttps://pharmaphorum.com/news/gsk-bolts-on-immuno-oncology-candidate-with-e3-7bn-merck-deal/
Campaigners urge NHS to ignore patents on Vertex’s CF drugThe fight to get Vertex’s cystic fibrosis drug Orkambi available on England’s NHS continues, after pressure groups called Share XCampaigners urge NHS to ignore patents on Vertex’s CF drughttps://pharmaphorum.com/news/campaigners-urge-nhs-to-ignore-patents-on-vertexs-cf-drug/
